Hala Borno, MD, Assistant Professor of Medicine, Department of Oncology and Hematology, University of California, San Francisco
Jamie Freedman, director of US Medical Affairs, Genentech.
Jennifer Jones-McMeans, PhD, Director of Global Clinical Affairs, Abbott Pharmaceuticals.
Marya Shegog, PhD, Health Equity and Diversity Coordinator, Lazarex Cancer Foundation.
Andrea Denicoff, Nurse and Nursing Advisor, National Cancer Institute; NCIs National Clinical Trials Network, Head of Clinical Trials Division.
‘Lola Fashoyin-Aje, MD, Assistant Director and Assistant Director, Disparity Eliminating Science and Policy, Oncology Competence Center, FDA.
Keanna Ghazvini, spokesperson for Pfizer Pharmaceuticals.
FDA: “Drug Trials Snapshots: NINLARO.”
National Cancer Institute: “NIH Guidelines and Guidelines for Inclusion of Women and Minorities as Subjects in Clinical Research”, “Inclusion of Women and Minorities as Participants in Research with Human Subjects”, “Cancer Differences”.
Clinicaltrials.gov: “ClinicalTrials.gov background.”
Lazarex Cancer Foundation.
Genentech Biotechnology Company.
Abbott Laboratories: “Abbott Announces Trial to Evaluate Espri Btk’s New Drug Eluting Absorbable Scaffold.”
Pfizer Pharmaceuticals.
American Cancer Society.
American Society for Clinical Oncology.
Contemporary Clinical Studies: “Does the COVID-19 Outbreak recognize a wider need to urgently transform research into cancer clinical trials?”
The New York Times: “Clinical trials move from the laboratory to people’s homes.”
Massey Cancer Center, Virginia Commonwealth University: “First Lady Jill Biden visits Massey to discuss cancer differences and community research.”
ProPublica: “Black patients are missing out on promising cancer drugs.”
Comments are closed.